Francis Julian White - Publications

Affiliations: 
Chicago Medical School, North Chicago, IL, United States 

123 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 McCutcheon JE, White FJ, Marinelli M. Individual differences in dopamine cell neuroadaptations following cocaine self-administration. Biological Psychiatry. 66: 801-3. PMID 19539267 DOI: 10.1016/j.biopsych.2009.04.018  1
2009 Sidiropoulou K, Lu FM, Fowler MA, Xiao R, Phillips C, Ozkan ED, Zhu MX, White FJ, Cooper DC. Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity. Nature Neuroscience. 12: 190-9. PMID 19169252 DOI: 10.1038/nn.2245  1
2006 Perez MF, White FJ, Hu XT. Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials. Journal of Neurophysiology. 96: 2217-28. PMID 16885524 DOI: 10.1152/jn.00254.2006  1
2006 Marinelli M, Rudick CN, Hu XT, White FJ. Excitability of dopamine neurons: modulation and physiological consequences. Cns & Neurological Disorders Drug Targets. 5: 79-97. PMID 16613555 DOI: 10.2174/187152706784111542  1
2006 Peterson JD, Wolf ME, White FJ. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 3164-8. PMID 16554467 DOI: 10.1523/JNEUROSCI.2375-05.2006  1
2005 Couceyro PR, Evans C, McKinzie A, Mitchell D, Dube M, Hagshenas L, White FJ, Douglass J, Richards WG, Bannon AW. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. The Journal of Pharmacology and Experimental Therapeutics. 315: 1091-100. PMID 16099925 DOI: 10.1124/jpet.105.091678  1
2005 McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proceedings of the National Academy of Sciences of the United States of America. 102: 9377-81. PMID 15967985 DOI: 10.1073/pnas.0503584102  1
2005 Nasif FJ, Hu XT, White FJ. Repeated cocaine administration increases voltage-sensitive calcium currents in response to membrane depolarization in medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3674-9. PMID 15814798 DOI: 10.1523/JNEUROSCI.0010-05.2005  1
2005 Hu XT, Ford K, White FJ. Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 916-26. PMID 15726118 DOI: 10.1038/sj.npp.1300654  1
2005 Dong Y, Nasif FJ, Tsui JJ, Ju WY, Cooper DC, Hu XT, Malenka RC, White FJ. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 936-40. PMID 15673674 DOI: 10.1523/JNEUROSCI.4715-04.2005  1
2005 Hu XT, Dong Y, Zhang XF, White FJ. Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. Journal of Neurophysiology. 93: 1406-17. PMID 15590733 DOI: 10.1152/jn.00771.2004  1
2005 Nasif FJ, Sidiropoulou K, Hu XT, White FJ. Repeated cocaine administration increases membrane excitability of pyramidal neurons in the rat medial prefrontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 312: 1305-13. PMID 15574686 DOI: 10.1124/jpet.104.075184  1
2004 Hu XT, Basu S, White FJ. Repeated cocaine administration suppresses HVA-Ca2+ potentials and enhances activity of K+ channels in rat nucleus accumbens neurons. Journal of Neurophysiology. 92: 1597-607. PMID 15331648 DOI: 10.1152/jn.00217.2004  1
2004 Dong Y, Cooper D, Nasif F, Hu XT, White FJ. Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3077-85. PMID 15044547 DOI: 10.1523/JNEUROSCI.4715-03.2004  1
2003 Marinelli M, Cooper DC, Baker LK, White FJ. Erratum to: Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology. 170: 334. PMID 29356872 DOI: 10.1007/s00213-003-1674-9  1
2003 Brandon CL, Marinelli M, White FJ. Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biological Psychiatry. 54: 1338-44. PMID 14675797 DOI: 10.1016/S0006-3223(03)00787-X  1
2003 Koeltzow TE, White FJ. Behavioral depression during cocaine withdrawal is associated with decreased spontaneous activity of ventral tegmental area dopamine neurons. Behavioral Neuroscience. 117: 860-5. PMID 12931970 DOI: 10.1037/0735-7044.117.4.860  1
2003 Peterson JD, Wolf ME, White FJ. Impaired DRL 30 performance during amphetamine withdrawal. Behavioural Brain Research. 143: 101-8. PMID 12842301 DOI: 10.1016/S0166-4328(03)00035-4  1
2003 Marinelli M, Cooper DC, Baker LK, White FJ. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology. 168: 84-98. PMID 12721782 DOI: 10.1007/s00213-003-1491-1  1
2003 Dong Y, White FJ. Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2686-95. PMID 12684454  1
2002 Hu XT, Koeltzow TE, Cooper DC, Robertson GS, White FJ, Vezina P. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse (New York, N.Y.). 45: 159-70. PMID 12112395 DOI: 10.1002/syn.10095  1
2002 Zhang XF, Cooper DC, White FJ. Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons. The Journal of Pharmacology and Experimental Therapeutics. 301: 1119-25. PMID 12023545 DOI: 10.1124/jpet.301.3.1119  1
2002 White FJ. A behavioral/systems approach to the neuroscience of drug addiction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3303-5. PMID 11978803  1
2001 Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 651-61. PMID 11682248 DOI: 10.1016/S0893-133X(01)00281-0  1
2001 White FJ. Neurobiology. Dopamine receptors get a boost. Nature. 411: 35, 37-8. PMID 11333962 DOI: 10.1038/35075193  1
2001 White FJ, Cooper DC. The vicious cyclin of addiction. Nature Medicine. 7: 416-7. PMID 11283665 DOI: 10.1038/86480  1
2000 Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8876-85. PMID 11102497  1
2000 Cooper DC, White FJ. L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo. Brain Research. 880: 212-8. PMID 11033010 DOI: 10.1016/S0006-8993(00)02868-7  1
2000 Li Y, White FJ, Wolf ME. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology. 151: 175-83. PMID 10972463  1
2000 Peterson JD, Wolf ME, White FJ. Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment. Synapse (New York, N.Y.). 36: 342-4. PMID 10819912 DOI: 10.1002/(SICI)1098-2396(20000615)36:4<342::AID-SYN11>3.0.CO;2-9  1
1999 Li Y, Wolf ME, White FJ. The expression of cocaine sensitization is not prevented by MK-801 or ibotenic acid lesions of the medial prefrontal cortex. Behavioural Brain Research. 104: 119-25. PMID 11125730 DOI: 10.1016/S0166-4328(99)00060-1  1
1999 Li Y, Hu XT, Berney TG, Vartanian AJ, Stine CD, Wolf ME, White FJ. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse (New York, N.Y.). 34: 169-80. PMID 10523754 DOI: 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C  1
1999 Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nature Neuroscience. 2: 649-55. PMID 10404198 DOI: 10.1038/10204  1
1999 Xu M, Koeltzow TE, Cooper DC, Tonegawa S, White FJ. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse (New York, N.Y.). 31: 210-5. PMID 10029239 DOI: 10.1002/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.0.CO;2-0  1
1998 Henry DJ, Hu XT, White FJ. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology. 140: 233-42. PMID 9860115 DOI: 10.1007/s002130050762  1
1998 White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug and Alcohol Dependence. 51: 141-53. PMID 9716936 DOI: 10.1016/S0376-8716(98)00072-6  1
1998 Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, ... ... White FJ, et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (New York, N.Y.). 281: 838-42. PMID 9694658 DOI: 10.1126/science.281.5378.838  1
1998 White FJ. Nicotine addiction and the lure of reward. Nature Medicine. 4: 659-60. PMID 9623965 DOI: 10.1038/nm0698-659  1
1998 White FJ. Cocaine and the serotonin saga. Nature. 393: 118-9. PMID 9603514 DOI: 10.1038/30105  1
1998 Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME, White FJ. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 2231-8. PMID 9482807  1
1998 Zhang XF, Hu XT, White FJ. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 488-98. PMID 9412525  1
1998 White FJ, Joshi A, Koeltzow TE, Hu XT. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 26-40. PMID 9408916 DOI: 10.1016/S0893-133X(97)00093-6  1
1998 White FJ, Hu XT, Zhang XF. Neuroadaptations in nucleus accumbens neurons resulting from repeated cocaine administration. Advances in Pharmacology (San Diego, Calif.). 42: 1006-9. PMID 9328068 DOI: 10.1016/S1054-3589(08)60917-5  1
1998 Hansen JB, Fink-Jensen A, Christensen BV, Grønvald FC, Jeppesen L, Mogensen JP, Nielsen EB, Scheideler MA, White FJ, Zhang XF. Mesolimbic selective antipsychotic arylcarbamates European Journal of Medicinal Chemistry. 33: 839-858. DOI: 10.1016/S0223-5234(99)80009-9  1
1997 Johnston RE, Hu XT, White FJ, Becker JB. Intrastriatal grafts of fetal ventral mesencephalic tissue restore quantitative and qualitative D1/D2 dopamine receptor synergism in the striatum. Restorative Neurology and Neuroscience. 11: 13-20. PMID 21551524 DOI: 10.3233/RNN-1997-111202  1
1997 Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology. 134: 266-76. PMID 9438676 DOI: 10.1007/s002130050449  1
1997 Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron. 19: 837-48. PMID 9354330 DOI: 10.1016/S0896-6273(00)80965-4  1
1997 White FJ, Hu XT, Zhang XF. DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes? Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 17: 91-5. PMID 9201729  1
1997 Zhang XF, Hu XT, White FJ, Wolf ME. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. The Journal of Pharmacology and Experimental Therapeutics. 281: 699-706. PMID 9152375  1
1997 Hu XT, White FJ. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neuroscience Letters. 224: 61-5. PMID 9132692 DOI: 10.1016/S0304-3940(97)13443-7  1
1997 White FJ. A new joint for marijuana smoke - Firing up dopamine reward circuits Neuroreport. 8: i.  1
1996 Cunningham KA, Henriksen SJ, Paris JM, Williams JT, White FJ. Electrophysical analyses of psychostimulant drug actions: from the slice to the awake animal. Nida Research Monograph. 162: 76-8. PMID 9066820  0.36
1996 Xu M, Hu XT, Cooper DC, White FJ, Tonegawa S. A genetic approach to study mechanisms of cocaine action. Annals of the New York Academy of Sciences. 801: 51-63. PMID 8959023 DOI: 10.1111/j.1749-6632.1996.tb17431.x  1
1996 White FJ. Synaptic regulation of mesocorticolimbic dopamine neurons. Annual Review of Neuroscience. 19: 405-36. PMID 8833449 DOI: 10.1146/annurev.ne.19.030196.002201  1
1996 Hu XT, White FJ. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo. Synapse (New York, N.Y.). 23: 208-18. PMID 8807749 DOI: 10.1002/(SICI)1098-2396(199607)23:3<208::AID-SYN10>3.0.CO;2-V  1
1995 Wachtel SR, White FJ. The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons. Neuroscience Letters. 199: 13-6. PMID 8584215 DOI: 10.1016/0304-3940(95)12025-Y  1
1995 Jeziorski M, White FJ. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. European Journal of Pharmacology. 275: 235-44. PMID 7768290 DOI: 10.1016/0014-2999(94)00779-7  1
1995 White FJ, Hu XT, Zhang XF, Wolf ME. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. The Journal of Pharmacology and Experimental Therapeutics. 273: 445-54. PMID 7714800  1
1995 Henry DJ, White FJ. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 6287-99. PMID 7666211  1
1994 Jeziorski M, White FJ, Wolf ME. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse (New York, N.Y.). 16: 137-47. PMID 8197575 DOI: 10.1002/syn.890160207  1
1994 Wolf ME, White FJ, Hu XT. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 1735-45. PMID 8126567  1
1994 Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79: 945-55. PMID 8001143 DOI: 10.1016/0092-8674(94)90026-4  1
1994 Hu XT, White FJ. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse (New York, N.Y.). 17: 43-61. PMID 7913772 DOI: 10.1002/syn.890170106  1
1994 Wolf ME, Xue CJ, White FJ, Dahlin SL. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Research. 666: 223-31. PMID 7882032 DOI: 10.1016/0006-8993(94)90776-5  1
1993 Wolf ME, White FJ, Hu XT. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behavioural Pharmacology. 4: 429-442. PMID 11224212  1
1993 White FJ, Hu XT, Henry DJ. Electrophysiological effects of cocaine in the rat nucleus accumbens: microiontophoretic studies. The Journal of Pharmacology and Experimental Therapeutics. 266: 1075-84. PMID 8355182  1
1993 Ackerman JM, Johansen PA, Clark D, White FJ. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics. 265: 963-70. PMID 8098768  1
1993 Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. The Journal of Pharmacology and Experimental Therapeutics. 264: 249-55. PMID 8093727  1
1993 Wolf ME, White FJ, Hu XT. Behavioral sensitization to MK-801 (dizocilpine) neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system Behavioural Pharmacology. 4: 429-442.  1
1992 Hu XT, White FJ. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Synapse (New York, N.Y.). 10: 206-16. PMID 1532677 DOI: 10.1002/syn.890100304  1
1992 White FJ. Neurophysiological approaches to receptor pharmacodynamics. Nida Research Monograph. 124: 35-55. PMID 1470214  1
1992 Henry DJ, Wise RA, Rompré PP, White FJ. Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists. Brain Research. 596: 231-7. PMID 1467986 DOI: 10.1016/0006-8993(92)91552-P  1
1992 Ackerman JM, White FJ. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. European Journal of Pharmacology. 218: 171-3. PMID 1397028 DOI: 10.1016/0014-2999(92)90161-V  1
1992 Henry DJ, White FJ. Electrophysiological correlates of psychomotor stimulant-induced sensitization. Annals of the New York Academy of Sciences. 654: 88-100. PMID 1385937  1
1992 Wachtel SR, Brooderson RJ, White FJ. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology. 109: 41-8. PMID 1365670 DOI: 10.1007/BF02245478  1
1992 Wachtel SR, White FJ. The effect of continuous and repeated administration of D1 dopamine receptor antagonist on midbrain dopamine neurons. Neurochemistry International. 20: 129S-133S. PMID 1365411 DOI: 10.1016/0197-0186(92)90225-G  1
1992 Hu XT, Brooderson RJ, White FJ. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Neuroscience. 50: 137-47. PMID 1357592 DOI: 10.1016/0306-4522(92)90388-I  1
1991 Henry DJ, White FJ. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics. 258: 882-90. PMID 1890623  1
1991 Johansen PA, Hu XT, White FJ. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. Journal of Neural Transmission. General Section. 86: 97-113. PMID 1683241 DOI: 10.1007/BF01250571  1
1990 Ackerman JM, White FJ. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neuroscience Letters. 117: 181-7. PMID 2290614 DOI: 10.1016/0304-3940(90)90141-U  1
1990 Brooderson RJ, White FJ, Galloway MP. Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors. Synapse (New York, N.Y.). 6: 395-7. PMID 2287994 DOI: 10.1002/syn.890060412  1
1990 White FJ, Hu XT, Brooderson RJ. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists. European Journal of Pharmacology. 191: 497-9. PMID 1982272 DOI: 10.1016/0014-2999(90)94188-4  1
1990 Hu XT, Wachtel SR, Galloway MP, White FJ. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2318-29. PMID 1973947  1
1989 Exner M, Furmidge LJ, White FJ, Clark D. Inhibitory effects of partial D2 dopamine receptor agonists on the d-amphetamine discriminative cue. Behavioural Pharmacology. 1: 101-111. PMID 11175393  1
1989 Jeziorski M, White FJ. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse (New York, N.Y.). 4: 267-80. PMID 2603146 DOI: 10.1002/syn.890040403  1
1989 Henry DJ, Greene MA, White FJ. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. The Journal of Pharmacology and Experimental Therapeutics. 251: 833-9. PMID 2557418  1
1989 Wachtel SR, Hu XT, Galloway MP, White FJ. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse (New York, N.Y.). 4: 327-46. PMID 2532422 DOI: 10.1002/syn.890040409  1
1988 Einhorn LC, Johansen PA, White FJ. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 100-12. PMID 3339402  1
1988 White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacology, Biochemistry, and Behavior. 30: 189-93. PMID 2902644 DOI: 10.1016/0091-3057(88)90442-X  1
1988 Johansen PA, Clarkl D, White FJ. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Life Sciences. 43: 515-24. PMID 2900459 DOI: 10.1016/0024-3205(88)90153-1  1
1988 Wachtel SR, White FJ. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. The Journal of Pharmacology and Experimental Therapeutics. 244: 410-6. PMID 2891845  1
1988 Henry DJ, White FJ. New potential antipsychotic drug BMY 20661: A profile of its effects on midbrain dopamine neurons Drug Development Research. 12: 211-220.  1
1987 White FJ. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. European Journal of Pharmacology. 135: 101-5. PMID 3494620 DOI: 10.1016/0014-2999(87)90764-3  1
1987 Clark D, White FJ. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse (New York, N.Y.). 1: 347-88. PMID 2971273 DOI: 10.1002/syn.890010408  1
1987 O'Brien DP, White FJ. Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity. European Journal of Pharmacology. 142: 343-54. PMID 2892684 DOI: 10.1016/0014-2999(87)90072-0  1
1986 White FJ. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions. Pharmacology, Biochemistry, and Behavior. 24: 365-79. PMID 3952127 DOI: 10.1016/0091-3057(86)90367-9  1
1986 White FJ. Electrophysiological investigations of the D-1 dopamine receptor. Clinical Neuropharmacology. 9: 29-31. PMID 2952270  1
1986 White FJ, Wang RY. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat. Neuropharmacology. 25: 995-1001. PMID 2877417 DOI: 10.1016/0028-3908(86)90193-0  1
1986 White FJ, Wang RY. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 274-80. PMID 2868077  1
1985 Wang RY, White FJ. Electrophysiological effects of cholecystokinin: central dopaminergic systems. Progress in Clinical and Biological Research. 192: 95-103. PMID 4080721  1
1985 Wang RY, White FJ, Voigt MM. Interactions of cholecystokinin and dopamine in the nucleus accumbens. Annals of the New York Academy of Sciences. 448: 352-60. PMID 2862829  1
1985 White FJ, Wang RY. Effects of chronic treatment with cholecystokinin on midbrain dopamine neurons Annals of the New York Academy of Sciences. 682-684.  1
1984 White FJ, Wang RY. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sciences. 34: 1161-70. PMID 6708722 DOI: 10.1016/0024-3205(84)90088-2  1
1984 White FJ, Wang RY. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. The Journal of Pharmacology and Experimental Therapeutics. 231: 275-80. PMID 6491980  1
1984 White FJ, Wang RY. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Research. 309: 283-92. PMID 6478223 DOI: 10.1016/0006-8993(84)90594-8  1
1984 White FJ, Wang RY. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain Research. 300: 161-6. PMID 6145498 DOI: 10.1016/0006-8993(84)91352-0  1
1983 White FJ, Wang RY. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat. Neuropharmacology. 22: 669-76. PMID 6888664 DOI: 10.1016/0028-3908(83)90089-8  1
1983 White FJ, Wang RY. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sciences. 32: 983-93. PMID 6827927 DOI: 10.1016/0024-3205(83)90929-3  1
1983 White FJ, Holohean AM, Appel JB. Antagonism of a behavioral effect of LSD and lisuride in the cat. Psychopharmacology. 80: 83-4. PMID 6408677 DOI: 10.1007/BF00427501  1
1983 White FJ, Wang RY. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science (New York, N.Y.). 221: 1054-7. PMID 6136093  1
1982 Appel JB, White FJ, Holohean AM. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neuroscience and Biobehavioral Reviews. 6: 529-36. PMID 7177512 DOI: 10.1016/0149-7634(82)90036-7  1
1982 Nielsen EB, White FJ, Holohean AM, Callahan PM, Appel JB. Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines. Life Sciences. 31: 2433-9. PMID 7154844 DOI: 10.1016/0024-3205(82)90747-0  1
1982 Holohean AM, White FJ, Appel JB. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. European Journal of Pharmacology. 81: 595-602. PMID 7117388 DOI: 10.1016/0014-2999(82)90349-1  1
1982 White FJ, Appel JB. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. The Journal of Pharmacology and Experimental Therapeutics. 221: 421-7. PMID 7077537  1
1982 White FJ, Appel JB. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science (New York, N.Y.). 216: 535-7. PMID 7071600  1
1982 White FJ, Appel JB. Training dose as a factor in LSD-saline discrimination. Psychopharmacology. 76: 20-5. PMID 6805003 DOI: 10.1007/BF00430748  1
1981 White FJ, Holohean AM, Appel JB. Lack of specificity of an animal behavior model for hallucinogenic drug action. Pharmacology, Biochemistry, and Behavior. 14: 339-43. PMID 7232460 DOI: 10.1016/0091-3057(81)90400-7  1
1981 White FJ, Appel JB. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology. 73: 110-5. PMID 6785800 DOI: 10.1007/BF00429199  1
1980 White FJ, Simmons MA, West KB, Holohean AM, Appel JB. The effect of serotonin depletion on the discriminability of LSD. Pharmacology, Biochemistry, and Behavior. 13: 569-74. PMID 6449014 DOI: 10.1016/0091-3057(80)90282-8  1
1979 Poling AD, White FJ, Appel JB. Discriminative stimulus properties of phencyclidine. Neuropharmacology. 18: 459-63. PMID 460541 DOI: 10.1016/0028-3908(79)90070-4  1
1979 White FJ, Appel JB, Kuhn DM. Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacology. 18: 143-51. PMID 34803 DOI: 10.1016/0028-3908(79)90054-6  1
1978 Kuhn DM, White FJ, Appel JB. The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology. 17: 257-63. PMID 652138 DOI: 10.1016/0028-3908(78)90109-0  1
1976 Kuhn DM, White FJ, Appel JB. Discriminable stimuli produced by hallucinogens. Psychopharmacology Communications. 2: 345-8. PMID 996285  1
Show low-probability matches.